References
- S.S. Davis, Nasal vaccines, Advanced Drug Del. Rev., 51, 21-42 (2001) https://doi.org/10.1016/S0169-409X(01)00162-4
- R. Glueck, Review of intranasal influenza vaccine, Advanced Drug Det. Rev., 51, 203-211 (2001) https://doi.org/10.1016/S0169-409X(01)00174-0
- C.W. Potter and R. Jennings, Intranasal immunization with inactivated influenza Vaccine, Pharm. Sci. & Tech. Today, 2, 402-408 (1999) https://doi.org/10.1016/S1461-5347(99)00194-7
- T.G. Boyce and G.A. Poland, Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum, Biomedic. & Pharmacother., 54, 210-218 (2000) https://doi.org/10.1016/S0753-3322(00)89027-7
- L.A. Jackson, S.J. Holmes, P.M. Mendelman, L. Huggins, I. Cho and J. Rhorer, Satety of a trivalent live attenuated intranasal influenza vaccine, FluMist[TM], administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions, Vaccine, 17, 1905-1909 (1999) https://doi.org/10.1016/S0264-410X(98)00471-X
- W.E.P. Beyer, A.M. Palache, J.C. de Jong and A.D.M.E.Osterhaus, Cold-adapted live influenza vaccine Vs inactivated vaccine: systemic vaccine reaction, local and systemic antibody response, and vaccine efficacy A meta-analysis, Vaccine, 20, 1340-1353 (2002) https://doi.org/10.1016/S0264-410X(01)00471-6
- R.B. Belshe, W.C. Gruber, P.M. Mendelman, I. Cho, K. Reisinger, S.L. Block, J. Wittes, D. lacuzio, P. Piedra, J. Treanor, J. King, K. Kotloff, D.I. Bernstein, F.G. Hayden, K. Zangwill, L. Yan and M. Wolff, Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine, J. Pediatr, 136, 168-175 (2000) https://doi.org/10.1016/S0022-3476(00)70097-7
- B. Morein and K.L. Bengtsson, Immunomodulation by iscoms, immune stimulating complexes, Methods, 19, 94-102 (1999) https://doi.org/10.1006/meth.1999.0833
- L. Illum, I.J. Gill, M. Hinchcliffe M, A.N. Fisher and S.S. Davis, Chitosan as a novel nasal delivery system for vaccine, Advanced Drug DeI. Rev., 51, 81-96 (2001) https://doi.org/10.1016/S0169-409X(01)00171-5
- K, Hashigucci, H. Ogawa, T. Ishidate, R. Yamashita, H. Kamiya, K. Watanabe and N. Hattori, Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-1bile enterotoxin B subunit containing a trace amount of the holotoxin, Vaccine, 14, 113-119 (1996) https://doi.org/10.1016/0264-410X(95)00174-Y
- U.-R. Gluck and J.O. Gebbers, Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-1bile toxin in adult volunteers, Virology, 73. 7780-7786 (1999)
- R. Gluck, R. Mischler, P. Durrer, E. Furer, A.B. Lang, C. Herzog and S.J. Cryz, Safety and immunogenicity of intranasally administered inactivated trivalent Virosomeformulated influenza vaccine containing Escherichia coli heat-1bile toxin as a mucosal adjuvant in young adult and elderlysubjects, J. Infectious Dia., 181, 1129-1132 (2000) https://doi.org/10.1086/315337
- T. Riley, S. Stolnik, C.R. Heald, C.D. Xiong, M.C. Gamett, L. Illum and S.S. Davis, Physicochemical evaluation of nanoparticles assembled from poly(lactic acid)-poly(ethyleneglycol) (PLA-PEG) block copolymers as drug delivery vehicles, Langmuir : The ACS J. Surfaces and CoIIoids, 17, 3168-3174 (2001)
- D.T. O'Hagan, Microparticles and polymers for the mucosal delivery of vaccines, Advanced Drug Det. Rev., 34, 305-320 (1998) https://doi.org/10.1016/S0169-409X(98)00045-3
- V. Michael and D.T. O'Hagan, Microparticles for intranasal immunization, Advanced Drug Del. Rev., 51, 127-141 (2001) https://doi.org/10.1016/S0169-409X(01)00167-3
- A. Vila, A. Sanchez, M. Tobio, C. Evora, I. Soriano, 0. Mc-Callion and M.J. Alonso, PLA-PEG nano and microparticles as carriers for nasal vaccine delivery, Pharm. Res., 15, 270-275(1998) https://doi.org/10.1023/A:1011922819926
- H. Murakami, M. Kobayashi, H. Takeuchi and Y. Kawashima, Preparation of poly(DL-Lactide-co-glycolide) nanoparticles by modified spotaneous emulsificadon solvent diffusion method, Int. J. Pharm., 187, 143-152 (1999) https://doi.org/10.1016/S0378-5173(99)00187-8
- O. Hiraku and M. Yoshiharu, Biodegradation and distribution of water-soluble chitosan in mice, Biomaterials, 20, 175-182 (1999) https://doi.org/10.1016/S0142-9612(98)00159-8
-
S.J. Park, S.H. Kim, I.R. Lee, H.B. Lee and S.K. Hong, Preparation and characterization of biodegradable poly(
\epsilon -caprolactone) microcapsules containing erythromycin by emulsion solvent evaporation technique Polymer(Korea), 26(3), 326 (2002) - H. Murakami, Y. Kawashima, T. Niwa, T. Hino, H. Takeuchi and M. Kobayashi, Influence of the degrees of hydrolyzation and polymerization of poly(vinylalcohol) on the preparation and properties of poly(DL-lactide-co-glycolide) nanoparticles, Int. J. Pharm., 149, 43-49 (1997) https://doi.org/10.1016/S0378-5173(96)04854-5